Tuesday, August 11, 2009

First Fosamax Trial Against Merck Begins Today

Am Law Daily's Priti Patnaik writes about the Boles case:

Starting Tuesday, pharma giant Merck & Co., Inc. faces the first trial over its osteoporosis drug Fosamax. More than 900 such lawsuits have been filed by more than 1,200 plaintiffs in state and federal courts. The suits claim that doctors were not warned that the drug may hamper blood flow to the jaw, causing jawbone-tissue death--osteonecrosis of the jaw, or ONJ. In some cases, ONJ leads to partial removal of the jaw.

Plaintiff Shirley Boles, 71, is represented by partner Timothy O'Brien and associates Meghan Tans and Ned McWilliams of Levin, Papantonio, Thomas, Mitchell, Echsner & Proctor. Michelle Parfitt and James Green at Ashcraft & Gerel are also working on the case.

Merck's trial team includes Paul Strain of Venable in Baltimore and Christy Jones of Butler, Snow, O'Mara, Steves & Cannada. Both represented Merck in the marathon Vioxx litigation. The company declined to name the other attorneys working on the case, saying that the information was part of its litigation strategy.

Interestingly, Judge Keenan has ruled that no punitive damages may be sought.



Pharmaceuticals - Misc., Products Liability | Permalink

TrackBack URL for this entry:


Listed below are links to weblogs that reference First Fosamax Trial Against Merck Begins Today:


Fosamax, A Bad Drug In Litigation by Jeffrey Dach MD

Bisphosphonates drugs like Fosamax have severe adverse side effects of jaw necrosis (OJN), spontaneous femur fracture, atrial fibrillation (a heart rhythm disturbance), and severe bone and joint pain. Another common adverse effect is esophageal erosion, heartburn and esophageal reflux.

Fosamax is a "bad drug" that should be banned.

Click Here for More:

Jeffrey Dach MD
4700 Sheridan Suite T
Hollywood Fl 33021

Posted by: jeffrey dach md | Sep 2, 2009 10:19:48 AM

It is interesting to note that the lawsuits filed by victims of the drug are moving, and not just placed in the corner. The drug has allegedly caused harm to these patients and the manufacturer has failed to do its part in warning health care providers about its danger. I do hope that patients may be well compensated by the drug company.

Posted by: John Collado | Sep 13, 2011 12:27:19 PM

Post a comment